Scaling the Everest of Pharma Synthesis: A Deep Dive into Eribulin's Journey 2024-04-19
As one steps into the realm of pharmaceutical discovery, the name Eribulin, also known as Halaven, rings a powerful note. First approved in 2010 by Eisai, this non-peptide drug, intricate in its synthesis and impressive in the magnitude of its medical impact, has been nothing short of groundbreaking
Read More